XML 33 R14.htm IDEA: XBRL DOCUMENT v3.24.1
Balance Sheet Components
12 Months Ended
Dec. 31, 2023
Balance Sheet Components  
Balance Sheet Components

7. Balance Sheet Components (in thousands):

December 31, 

    

2023

    

2022

Prepaid and Other Current Assets

Interest receivable

$

37

$

45

Prepaid research and development manufacturing expenses

149

192

Prepaid facility expenses

196

182

Prepaid insurance

179

252

Other

 

220

 

102

$

781

$

773

Property and Equipment

Laboratory equipment

$

2,678

$

2,673

Computer equipment and purchased software

 

171

 

142

Leasehold improvements

 

2,084

 

2,084

 

4,933

 

4,899

Less: accumulated depreciation and amortization

 

(4,697)

 

(4,546)

$

236

$

353

Accrued and Other Liabilities

Accrued clinical trial expense

$

2,302

$

2,934

Accrued manufacturing expense

 

675

 

3,254

Personnel related

 

684

 

1,113

Accrued legal and accounting

64

89

Other

 

245

 

158

$

3,970

$

7,548

During the years ended December 31, 2023, 2022, and 2021, the Company recorded $0.2 million, $0.4 million and $0.5 million in depreciation expense, respectively.